Register

Molecular Medicine Tri-Conference 2010
February 3 - 5,2010  San Francisco,CA,USA


(SC1) Applying Next Generation Sequencing Technologies to Research
(SC2) One Case Study in Breast Cancer-Three Perspectives
(SC3) Mighty Mitochondria: Their Relevance to Disease and Translational Medicine
(SC4) Addressing Safety Concerns for Biological Drugs
(SC5) Targeting Cancer Stem Cells with Biologics
(SC6) Dealing with the Blood-Brain Barrier
(SC7) Best Practices in Translational & Personalized Medicine
(SC8) Strategies for Molecular Diagnostic Companies
(SC9) Fragment-Inspired Medicinal Chemistry
(SC10) TransSporter-Mediated Drug-Drug Interaction Potential: Strategies for In Vitro Characterization
(SC11) Basic Immersion in Cutting Edge Science and Technology for Biotech and Pharma
(SC12) Designing Rigorous Omics Studies for Biomarker Discovery and Development of Prognostic and Predictive Molecular Diagnostics
Exhibit & Sponsorship
CHI’s Molecular Medicine Tri-Conference event is unique in that it brings together the therapeutic and diagnostic aspects of the industry in one place. This gives your company a variety of sponsorship options to maximize its exposure among leading scientists and executives within your target audience as well as the opportunity to reach related audiences.


 

Stay Connected with CHI's Tri-Conference

 

Testimonials

quotes

 

Corporate Sponsors

     



Corporate Support Sponsors

 
 
Choose your language
Japanese Traditional Chinese Simplified Chinese Korean

2010 Final Brochure

 

PremierSponsor




Co-Sponsors

Lead Sponsoring Publications


 

 

Market Research Report

 

Cambridge Healthtech Institute
Global Information, Inc. - International Marketing Partner of Cambridge Healthtech Institute.

Your Life Science Network